Stay updated on DM199 Safety & Tolerability in Acute Ischemic Stroke Clinical Trial
Sign up to get notified when there's something new on the DM199 Safety & Tolerability in Acute Ischemic Stroke Clinical Trial page.

Latest updates to the DM199 Safety & Tolerability in Acute Ischemic Stroke Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with the site header and footer, indicating restricted access to the study record.SummaryDifference17%

- Check55 days agoChange DetectedUpdated the page revision tag from v3.6.5 to v3.6.6. This indicates a new release of the page metadata without altering the study content or user-facing details.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.5 instead of v3.6.4, indicating a small backend/frontend update to the site. It does not modify the study details or how the information is presented.SummaryDifference0.1%

- Check92 days agoChange DetectedA new bibliographic citation for the ReMEDy1 study is added to Publications, listing a 2026 Int J Stroke article on Rinvecalinase Alfa (DM199) for acute ischemic stroke, while the previous ahead-of-print citation is removed.SummaryDifference0.1%

Stay in the know with updates to DM199 Safety & Tolerability in Acute Ischemic Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DM199 Safety & Tolerability in Acute Ischemic Stroke Clinical Trial page.